JCH vs. WWH, MYI, ATT, VEIL, N91, FEV, PNL, WTAN, BRW, and BHMU
Should you be buying JPMorgan Claverhouse stock or one of its competitors? The main competitors of JPMorgan Claverhouse include Worldwide Healthcare (WWH), Murray International (MYI), Allianz Technology Trust (ATT), Vietnam Enterprise (VEIL), Ninety One Group (N91), Fidelity European Trust (FEV), Personal Assets (PNL), Witan Investment Trust (WTAN), Brewin Dolphin (BRW), and BH Macro USD (BHMU). These companies are all part of the "asset management" industry.
JPMorgan Claverhouse vs. Its Competitors
JPMorgan Claverhouse (LON:JCH) and Worldwide Healthcare (LON:WWH) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.
Worldwide Healthcare has a net margin of 92.78% compared to JPMorgan Claverhouse's net margin of 92.61%. JPMorgan Claverhouse's return on equity of 14.30% beat Worldwide Healthcare's return on equity.
JPMorgan Claverhouse has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Worldwide Healthcare has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500.
11.7% of JPMorgan Claverhouse shares are held by institutional investors. Comparatively, 10.2% of Worldwide Healthcare shares are held by institutional investors. 0.1% of JPMorgan Claverhouse shares are held by company insiders. Comparatively, 0.2% of Worldwide Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
JPMorgan Claverhouse pays an annual dividend of GBX 0.35 per share and has a dividend yield of 0.0%. Worldwide Healthcare pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.0%. JPMorgan Claverhouse pays out 60.2% of its earnings in the form of a dividend. Worldwide Healthcare pays out -6.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
In the previous week, Worldwide Healthcare had 1 more articles in the media than JPMorgan Claverhouse. MarketBeat recorded 1 mentions for Worldwide Healthcare and 0 mentions for JPMorgan Claverhouse. Worldwide Healthcare's average media sentiment score of 1.81 beat JPMorgan Claverhouse's score of 0.00 indicating that Worldwide Healthcare is being referred to more favorably in the news media.
Worldwide Healthcare has lower revenue, but higher earnings than JPMorgan Claverhouse. Worldwide Healthcare is trading at a lower price-to-earnings ratio than JPMorgan Claverhouse, indicating that it is currently the more affordable of the two stocks.
Summary
JPMorgan Claverhouse beats Worldwide Healthcare on 9 of the 15 factors compared between the two stocks.
Get JPMorgan Claverhouse News Delivered to You Automatically
Sign up to receive the latest news and ratings for JCH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding JCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
JPMorgan Claverhouse Competitors List
Related Companies and Tools
This page (LON:JCH) was last updated on 8/31/2025 by MarketBeat.com Staff
